Functional imaging of
photosensitizers using multiphoton microscopy.
In April 2000, the U.S. Food and Drug Administration (FDA) approved the production of Visudyne, a QTL - produced
photosensitizer used in the treatment of macular degeneration.
Not exact matches
Photodynamic therapy (PDT), involves the
use of chemicals called
photosensitizers that are activated by exposure to specific wavelengths of light to release reactive molecules that can damage nearby cells.
Researchers note that while PCI - aided delivery of chemotherapy to the brain has proven effective in laboratory tests, additional testing prior to human clinical trials is needed to identify other less - toxic blood - brain barrier agents to be
used in tandem with the
photosensitizer in the PCI process.